Adam Kaye
At Pacific Since: 1995
Adam M. Kaye '95, PharmD, FASCP, FCPhA earned his doctor of pharmacy from University of the Pacific in 1995. He originally chose to pursue pharmacy after watching his mother deal with immeasurable suffering due to chronic pain, migraines and other health conditions. His career has also been influenced by his older brother who is an anesthesiologist.
Dr. Kaye loves the size of Pacific, which allows for close teacher-student interactions and for faculty to be accessible to students. He is grateful that at Pacific the faculty invest their time in helping students prepare for their careers in pharmacy. Dr. Kaye enjoys teaching students about pharmacology and therapeutics in order to prepare them to be practice-ready professionals. He is thrilled to have the opportunity to give back to his alma mater and his profession. His goal is to provide students with the knowledge needed to be competent, confident and inquisitive about their patients' medications and health conditions.
Dr. Kaye is actively involved in the San Joaquin Pharmacists Association, where he served four terms as President, and the California Pharmacists Association. He is also the Editorial Advisor for the Pharmacist's Letter, the Prescriber's Letter and the Pharmacy Technician's Letter. In addition, he has been the co-author of the Ident-A-Drug reference book since the late 1990s and has co-authored numerous chapters on pain and anesthesia. He is also a member of the American Society of Consultant Pharmacists and American Society of Interventional Pain Physicians, as well as serving on the Advisory Board for the Pharmacist's Letter. Dr. Kaye is also a consultant to various physicians, healthcare organizations, attorneys and pharmacy technician educational training programs.
Dr. Kaye was born in New York; he later lived in Los Angeles and Arizona before settling in Stockton. His favorite thing about Stockton is that it is a small town, which makes it easier to meet people. He enjoys spending time with his wife and daughter. Dr. Kaye's interests include basketball and tennis.
PharmD, University of the Pacific, 1995
Teaching Philosophy
"A curious student will become a lifelong learner. This profession requires the constant acquisition of new knowledge, ideas and thought processes. Don't sit back and wait for the education to come to you- go after it and acquire it on your own!"
Courses
PHRM 129 — Community I IPPE
Research Summary
"Patient medication safety advocate."
Research Interests
- Chronic Pain
- Psychiatric pharmacology
- Insomnia
- Herbal
- OTC therapeutics
- Serotonin Syndrome
- Pancreatitis
- Rhabdomyolysis
- QT Prolongation and Torsades de Pointes
- Stevens-Johnson syndrome
- zolpidem /Ambien-induced behaviors/sleep driving
- Requip/Mirapex
- Compulsive Behavior/Gambling Addiction
- American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain
Scholarly Activity
Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care | Kaye | Springer
Adam M. Kaye et al. published “Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects” in Neurology International, August 22, 2022.
Adam M. Kaye et al. published “Buprenorphine and its formulations: a comprehensive review” in Health Psychology Research, August 20, 2022.
Adam M. Kaye et al. published “Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review” in Health Psychology Research, April 25, 2022.
Adam M. Kaye et al. published “Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update” in Health Psychology Research, July 28, 2022.
Adam M. Kaye et al. published “Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review” in Health Psychology Research, July 28, 2022.
Adam M. Kaye et al. published “Transcranial Magnetic Stimulation for Post-traumatic Stress Disorder” in Frontiers in Psychiatry, May 31, 2022.
Adam M. Kaye et al. published “Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence” in Neurology International, May 18, 2022.
Adam M. Kaye et al. published “Neurological and Psychiatric Symptoms of COVID-19: A Narrative Review” in Psychiatry International, May 7, 2022.
Adam M. Kaye et al. published “Addiction and COVID: Issues, Challenges, and New Telehealth Approaches” in Psychiatry International, May 13, 2022.
Adam M. Kaye et al. published “Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review” in Neurology International, March 17, 2022.
Adam M. Kaye et al. published “The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease” in Neurology International, March 22, 2022.
Adam M. Kaye et al. published “Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer’s Disease: A Comprehensive Review” in Health Psychology Research, Jan. 30, 2022.
Adam M. Kaye et al. published “Sexual Dysfunction in Schizophrenia: A Narrative Review of the Mechanisms and Clinical Considerations” in Psychiatry International, Dec. 22, 2021.
Adam M. Kaye et al. published “Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder” in Frontiers in Psychiatry, Dec. 17, 2021.
Adam M. Kaye et al. published “Attention Deficit Hyperactivity Disorder and Bipolar Disorder: Diagnosis, Treatments, and Clinical Considerations: A Narrative Review” in Psychiatry International, Dec. 21, 2021.
Adam M. Kaye et al. published “Opicapone for the Treatment of Parkinson's Disease ‘Off’ Episodes: Pharmacology and Clinical Considerations” in Clinical Drug Investigation, Dec. 21, 2021.
Adam M. Kaye et al. published “Bremelanotide for Treatment of Female Hypoactive Sexual Desire” in Neurology International, Jan. 4, 2022.
Adam M. Kaye et al. published “Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complications, and Postnatal Risks” in Neurology International, Jan. 3, 2022.
Adam M. Kaye et al. published “Naltrexone Implant for Opioid Use Disorder” in Neurology International, Dec. 30, 2021.
Adam M. Kaye et al. published “Conolidine: A Novel Plant Extract for Chronic Pain” in Anesthesiology and Pain Medicine, Dec. 8, 2021.
Adam M. Kaye et al. published “Catatonia: Clinical Overview of the Diagnosis, Treatment, and Clinical Challenges” in Neurology International, Nov. 8, 2021.
Adam M. Kaye et al. published “Benzodiazepines: Uses, Dangers, and Clinical Considerations” in Neurology International, Nov. 10, 2021.
Adam M. Kaye et al. published “Brexanolone, a GABAA Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review” in Frontiers in Psychiatry, Sept. 14, 2021.
Adam M. Kaye et al. published “Pharmacological Advances in Opioid Therapy: A Review of the Role of Oliceridine in Pain Management” in Pain and Therapy, Sept. 4, 2021.
Adam M. Kaye et al. published “Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations” in Anesthesiology and Pain Medicine, Sept. 6, 2021.
Adam M. Kaye et al. published “Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations” in Neurology International, Sept. 1, 2021.
Adam M. Kaye et al. published “Clozapine and Constipation: A Review of Clinical Considerations and Treatment Options” in Psychiatry International, Sept. 1, 2021.
Adam M. Kaye et al. published “Novel Regional Nerve Blocks in Clinical Practice: Evolving Techniques for Pain Management” in Anesthesiology and Pain Medicine, Aug. 29, 2021.
Adam M. Kaye et al. published “MDMA to Treat PTSD in Adults” in Psychopharmacology Bulletin, June 1, 2021.
Adam M. Kaye et al. published “Paliperidone to Treat Psychotic Disorders” in Neurology International, July 28, 2021.
Adam M. Kaye et al. published “Adjuvant Drugs for Peripheral Nerve Blocks: The Role of Alpha-2 Agonists, Dexamethasone, Midazolam, and Non-steroidal Anti-inflammatory Drugs” in Anesthesiology and Pain Medicine, July 4, 2021.
Adam M. Kaye et al. published “Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric Modulator of GABAA Ion Channels, for Partial Onset Seizures in Adults: A Comprehensive Review and Clinical Implications” in Neurology International, April 21, 2021.
Adam M. Kaye et al. published “Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications” in Psychopharmacology Bulletin, March 16, 2021.
Adam M. Kaye et al. published “Brexanolone to Treat Postpartum Depression in Adult Women” in Psychopharmacology Bulletin, March 16, 2021.
Adam M. Kaye et al. published “Lamotrigine and Stevens-Johnson Syndrome Prevention” in Psychopharmacology Bulletin, March 16, 2021.
Adam M. Kaye et al. published “Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice” in Psychopharmacology Bulletin, March 16, 2021.
Adam M. Kaye and A.D. Kaye presented “Controlled Substance Pharmacology: Non-Opioids, Benzodiazepines, Sedatives, and Hypnotics: The Relevance to Pain Physician” at the American Society of Interventional Pain Physicians (ASIPP) Controlled Substance Management Comprehensive Review Course Webinar, held virtually April 24-25, 2021.
Adam M. Kaye and A.D. Kaye presented “Role of Antipyretics, Analgesics, Antidepressants, and Anticonvulsants in Pain Medicine” at the 2021 ASIPP Controlled Substance Management Comprehensive Review Course Webinar.
Adam M. Kaye and A.D. Kaye presented “Opioid Pharmacology, Interactions, and Side Effects: Practical Applications” at the 2021 ASIPP Controlled Substance Management Comprehensive Review Course Webinar.
Adam M. Kaye and A.D. Kaye presented “Abuse Deterrent Technologies: Facts and Fiction” at the 2021 ASIPP Controlled Substance Management Comprehensive Review Course Webinar.
Adam M. Kaye coauthored “Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP)” Pain Physician, March 2020.
Adam M. Kaye coauthored “The Utilization of Buprenorphine in Chronic Pain” Best Practice & Research Clinical Anaesthesiology, September 2020.
Adam M. Kaye coauthored “Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults” Psychopharmacology Bulletin, 2020.
Adam M. Kaye coauthored “Lumateperone for the Treatment of Schizophrenia” Psychopharmacology Bulletin, 2020.
Adam M. Kaye coauthored “Asenapine Transdermal Patch for the Management of Schizophrenia” Psychopharmacology Bulletin, 2020.
Adam M. Kaye coauthored “Naldemedine for the Use of Management of Opioid Induced Constipation” Psychopharmacology Bulletin, July 23, 2020.
Adam M. Kaye coauthored “Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines” Pain Physician, Jan. 2019.
Adam M. Kaye coauthored the following book chapters: "Special Concerns Regarding Commonly Prescribed Drugs," in Understanding Pain: What You Need to Know to Take Control, Praeger, September 2011; and "Pharmacology," in Moderate and Deep Sedation in Clinical Practice, Cambridge University Press, December 2011.
Adam M. Kaye coauthored the book chapter "Anticoagulation and Regional Anesthesia Considerations" for Essentials of Regional Anesthesia, published by Springer, December 2011.
Adam M. Kaye coauthored the book chapter "Anticoagulation and Regional Anesthesia Concerns," published in Essentials of Regional Anesthesia, Kaye, Urman and Vadivelu, eds. Springer, 2012.
“Understanding Pain-What You Need to Know to Take Control,” Editors: Alan D. Kaye, MD, PhD and Richard D.Urman, MD, MBA, Chapter 7, "Special Concerns Regarding Commonly Prescribed Drugs" Adam M. Kaye and Alan D. Kaye. ISBN: 0313396035,9780313396038. In Press.
"Moderate and Deep Sedation in Clinical Practice," Editors: Richard D. Urman and Alan D. Kaye. Chapter-2- Pharmacology. Julie Gayle, MD, Alan D. Kaye, MD, PhD, Adam M. Kaye. ISBN: 1107400457,978110740045. In press.
"Foundations-Comprehensive Pain Medicine and Interventional Pain Management Review" Chapter 6 "Neuroleptic Drugs" by Ryan P. Ellender, MD, Alan D. Kaye, MD, PhD, Adam M. Kaye; Chapter 10 "Muscle Relaxants and Antispacticity Drugs" by M. Tyler Stout, MD, Alan D. Kaye, MD, PhD, Adam M. Kaye; Chapter 11 "NMDA Receptor Antagonists" by Brad J. Hynel MD, Alan D. Kaye, MD, PhD, Adam M. Kaye. in press.
"Essentials of Regional Anesthesia", edited by A.D. Kaye, Richard D. Urman, and Nalini Vadivelu.Chapter 6: "Anticoagulation and Regional Anesthesia Considerations" Rhinoo V. Shah, Alan D. Kaye, Adam M. Kaye and Jeffrey Y. Tsai, in press.
Adam M. Kaye coauthored "Ident-A-Drug Reference" Publisher: Pharmacists Letter, 2011.
Adam M. Kaye contributed to American Society of Interventional Pain Physicians (ASIPP) Pain Medicine & Interventional Pain Management "Board Review Self-Assessment," 2011, American Society of Interventional Pain Physicians.
Adam M. Kaye coauthored Mirapex (pramipexole), Requip (ropinirole) and Impulse Control Disorders, June 18, 2012, Articles-RxEconsult, LLC.
Adam M. Kaye and Jessica S. Kaye, Anticoagulants and Medications that Increase Risk of Bleeding. June 16, 2012. Featured Articles- RxEconsult, LLC.
Adam M. Kaye, Over-the-Counter (OTC) Antihistamines for Allergies. Featured Articles-RxEconsult, LLC. June 16, 2012.
Adam M. Kaye and Jessica S. Kaye, Over-the-Counter (OTC) Products for Insomnia. Featured Articles- RxEconsult, LLC. June 15, 2012.
Adam M. Kaye and Jessica S. Kaye, Opioid+NSAID Combinations and Stomach Bleeding. Featured Articles- RxEconsult, LLC. June 15, 2012.
Adam M. Kaye and Jessica S. Kaye, Should Statins be Used by Individuals with Low Risk for Heart Disease. Featured Articles- RxEconsult, LLC. June 15, 2012.
Adam M. Kaye and Jessica S. Kaye, Prescription and Over-The-Counter (OTC) Acne Preparations. Featured Articles- RxEconsult, LLC. June 14, 2012.
Adam M. Kaye, Should Vicodin and other Hydrocodone Products be Switched to Schedule II. Featured Articles- RxEconsult, LLC. June 2, 2012.
Adam M. Kaye, How PBMs Affect the Future of Community Pharmacy. Featured Articles-RxEconsult, LLC. June 3, 2012
Adam M. Kaye, How to Become a Pharmacist Expert Witness. Featured Articles- RxEconsult, LLC. May 31, 2012.
Alvah T. Wickboldt, Alex F. Bowen, Aaron J. Kaye, Adam M. Kaye, Franklin Rivera Bueno, Alan D. Kaye, (2012) Sleep Physiology, Abnormal States, and Therapeutic Interventions. The Ochsner Journal: Summer 2012, Vol. 12, No. 2, pp. 122-134.
